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Hyperlipidemia is one of the major risk factors of atherosclerosis and other cardiovascular
diseases. This study aimed to investigate the impact of leucine rich pentatricopeptide
repeat containing protein (LRPPRC)-driven hepatic oxidative phoshorylation on blood
lipid levels. The hepatic LRPPRC level was modulated by liver-specific transgenic or
adeno-associated virus 8 carried shRNA targeting Lrpprc (aav-shLrpprc). Mice were fed
with a high fat diet to induce obesity. Gene expression was analyzed by quantitative
real-time PCR and / or western blot. The hepatic ATP level, hepatic and serum
lipids contents, and mitochondria oxidative phosphorylation (OxPhos) complex activities
were measured using specific assay kits. The uptake and oxidation of fatty acid by
hepatocytes were assessed using 14C-palmitate. LRPPRC regulated the expression of
genes encoded by mitochondrial genome but not those by nuclear genome involved
in mitochondria biogenesis, OxPhos, and lipid metabolism. Increased OxPhos in liver
mediated by LRPPRC resulted in the increase of hepatic ATP level. Lrpprc promoted
palmitate uptake and oxidation by hypatocytes. The hepatic and serum triglyceride and
total cholesterol levels were inversely associated with the hepatic LRPPRC level. These
data demonstrated that LRPPRC-driven hepatic OxPhos could promote fatty acids
uptake and oxidation by hepatocytes and reduce both hepatic and circulating triglyceride
and cholesterol levels.
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INTRODUCTION
Hyperlipidemia and hypertension are increasingly prevalent both in the United States (Go et al.,
2014) and globally (Hanevold, 2013) in both adult and pediatric populations. Lipid-driven chronic
arterial wall inflammation is responsible for initiation and progression of atherosclerosis which
is one of the diseases causing most death (Buckley and Ramji, 2015; Zarzycka et al., 2015).
Atherosclerosis is the underlying cause for myocardial infarction, stroke, incident heart failure,
renal failure and other vascular diseases (Lloyd-Jones et al., 2002), which results in great life,
emotional, and financial burdens.
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Hyperlipidemia and non-alcoholic fatty liver diseases
(NAFLD) are highly associated (Abe et al., 2012; Wang et al.,
2013; Tomizawa et al., 2014). Mitochondrial dysfunction
increases predisposition to intracellular lipid accumulation
(Morino et al., 2006; Schrauwen et al., 2010; Su et al., 2010) and
non-alcoholic steatohepatitis (NASH) (Cortez-Pinto et al., 1999;
Sanyal et al., 2001; Pérez-Carreras et al., 2003; Rector et al., 2010).
Mitochondrial oxidative phosphorylation (OxPhos) activities
are decreased in patients with fatty liver disease (Cortez-Pinto
et al., 1999; Pérez-Carreras et al., 2003). OxPhos has been
manipulated to alleviate lipotoxicity and NAFLD (Lelliott et al.,
2007; Pospisilik et al., 2007; Bellafante et al., 2013). Disrupting
mitochondrial function by knocking out paraoxonase 3 gene
(Pon3) causes significant increases of mouse plasma and hepatic
cholesterol levels, hepatotoxicity markers in circulation, gallstone
weight, and mortality (Shih et al., 2015). Ectopic expression
of peroxisome proliferator-activated receptor γ coactivator-1β
(PGC-1β) promotes mitochondrial biogenesis, lipid export, fatty
acid oxidation, and OxPhos (Lelliott et al., 2007; Bellafante et al.,
2013).
Leigh Syndrome French Canadian variant, a rare form of
Leigh Syndrome, is caused by mutations in the gene encoding
leucine-rich pentatricopeptide repeat-containing protein
(LRPPRC) (Mootha et al., 2003). Although the mechanism is
still controversial, LRPRPC is mainly located in mitochondria
and regulates the expression of genes harbored on mitochondrial
genome (Sasarman et al., 2010; Sondheimer et al., 2010; Liu et al.,
2011; Ruzzenente et al., 2012; Xu et al., 2012; Harmel et al., 2013;
Mourier et al., 2014). As LRPPRC has been shown to regulate
mitochondrial oxidative respiration, fatty acid oxidation, and
TABLE 1 | The sequences of qPCR primers used in this study.
Gene Oligonucleotide sequences
ND1 CCCCTTCGACCTGACAGAAG GGGCCGGCTGCGTATT
ND2 CAAGGGATCCCACTGCACAT GAGTAGCGGGTAGATTTGGATTAAAA
ND4 ATCACTCCTATTCTGCCTAGCAAAC GAAGTCCTCGGGCCATAATTATAGT
ND6 GGCCTGGAATTCAGCCTACTAG TGTTATGTTAAGGATAAGACCGTTTGTT
CytB AGACAACTACATACCAGCTAATCCACTAA GAATGGCGTATGCAAATAGGAAA
COX1 TTTTCAGGCTTCACCCTAGATGA CCTACGAATATGATGGCGAAGTG
COX3 GCAGGATTCTTCTGAGCGTTCT GTCAGCAGCCTCCTAGATCATGT
ATP6 AATTACAGGCTTCCGACACAAAC TGGAATTAGTGAAATTGGAGTTCCT
ATP8 GCCACAACTAGATACATCAACATGATT GGTTGTTAGTGATTTTGGTGAAGGT
Lrpprc TTCAGTGCTCTCGTCACAGG GTCGCGGTCCATGAAGTAAT
PGC-1α ATGTGTCGCCTTCTTGCTCT ATCTACTGCCTGGGGACCTT
PGC-1β TAGGAGGGAGGCAAACCAGA AGTGCTTTGTGAGACTGGCA
ERRα GCAGGGCAGTGGGAAGCTA CCTCTTGAAGAAGGCTTTGCA
Tfam GGGAATGTGGAGCGTGCTAA GATAGACGAGGGGATGCGAC
Ndufs1 GCGCTTCGAGTGGTGTTTTCT TCAAGGGCAAGAGGAGAACGG
Sdha GCTGGTGTGGATGTCACTAAGG CCCACCCATGTTGTAATGCA
Uqcrb CGGGCCGATCTGCTGTT ACCACTTTCGAAAACCATCCA
Cox5A TGATGCCTGGGAATTGCGT ACAACCTCCAAGATGCGAACA
Atp5S ATTGATGCCACCGATTCTTGTA GCTCTAGGCCCACCATGTGA
β-Actin GGTCATCACTATTGGCAACG ACGGATGTCAACGTCACACT
18S rRNA AAACGGCTACCACATCCAAG CCTCCAATGGATCCTCGTTA
hepatic lipid content (Liu et al., 2011; Mourier et al., 2014; Akie
et al., 2015), this study aims to investigate whether changes in
hepatic LRPPRC-driven mitochondrial OxPhos could impact
hepatic and circulating lipid levels.
MATERIALS AND METHODS
Animal Models
All animal experiments were performed conform with the NIH
guide for the care and use of laboratory animals and protocols
were approved by the IACUC of China Three Gorges University
(Yichang, China). C57BL/6 mice were purchased from the
Laboratory Animal Center of Northwest University and housed
in a room with controlled temperature of 22–23◦C and 12 h
light/12 h dark cycle. Liver specific Lrpprc transgenic mouse was
established as previously described (Liu et al., 2011) and back
crossed with C57BL/6 mice for at least 8 generations. C-terminal
myc-tagged murine Lrpprc gene expression was under the
control of transthyretin (ttr) promoter, which is liver-specifically
expressed (Wu et al., 1996). The pTTR1ExV3 was a gift from
Dr. Terry Van Dyke (University of North Carolina). DNA
microinjection into fertilized C57BL/6 embryos was performed
by the transgenic core of Northwest University. To generate liver-
specific Lrpprc knockdown mice, adeno-associate virus serotype
8 shLrpprc (aav-shLrpprc) (Liu et al., 2011) and aav-shCtrl (100
µl of 1011 pfu/ml) (HanBio, Shanghai, China) were injected into
6-week old C57BL/6 male mice (n = 20 each group) through
tail vein. At 8 weeks old, C57BL/6, Lrpprc transgenic mice, and
aav-injected mice were randomly divided into two subgroups
(n= 10) to be fed with either regular chow (Harlan Laboratories,
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Indianapolis, IN) or high-fat diet with about 55% kcal from
fat (approximate fatty acid profile (% total fat): 28% saturated,
30% trans, 28% cis-monounsaturated, 14% cis-polyunsaturated)
(Teklad TD-93075, Harlan Laboratories) for 9 weeks. Then the
mice were fasted for 12 h before blood samples were collected
andmice were sacrificed by CO2 euthanasia and liver tissues were
flash-frozen in liquid nitrogen for further experiments.
Histology Examination
Liver histology was assessed by hematoxylin and eosin (HE)
staining with standard procedure.
Serum and Liver Lipid Contents
Serum triglyceride, cholesterol, and free fatty acids levels were
measured using Triglyceride Colorimetric Assay kit (10010303,
Cayman Chemical Company, Ann Arbor, MI), Cholesterol
Fluorometric Assay Kit (10007640, Cayman), and Free Fatty
Acid Fluorometric Assay Kit, (700310, Cayman), according to
the manufacturers’ protocols. Liver total lipid was extracted
with previously described method (Folch et al., 1957) and
the triglyceride and cholesterol levels were measured using
aforementioned kits.
Western Blot
Total tissue proteins were obtained by homogenizing mouse
liver tissue in RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM
NaCl, 1% Triton x-100, 1% Sodium deoxycholate, 0.1% SDS, 1
mM EDTA) including a protease inhibitor cocktail (Sigma, St.
Louis, MO) and resolved on SDS-PAGE (Invitrogen, Beijing,
China) before transferred to a PVDF membrane and blocked
with 5% BSA in TBST (50 mM Tris, 150 mM NaCl, 0.1%
Tween-20, pH 7.6) for 1 h. The membranes were incubated
with primary antibody overnight at 4◦C followed by washed
three times with TBST then probed with appropriate secondary
antibodies for 1 h at room temperature, washed as above
and proteins bands were detected using ECL (EMD Millipore,
Shanghai, China). Anti-LRPPRC (ab80881, Abcam, Shanghai,
China), COX1 (ab14705), COX5A (ab110262), and β-Actin
(ab8227) antibodies were diluted according to the manufacturer
instructions.
Quantitative Real-Time RNA Polymerase
Chain Reaction (RT-qPCR)
Liver total RNA was extracted using RNeasy mini kit
(Qiagen, Shanghai, China). The cDNA was synthesized
using SuperScriptTM III First-Strand Synthesis SuperMix
(Life Technologies, Shanghai, China). Quantitative PCR was
done using SYBRgreen master mix (Qiagen) according to
manufacturer’s instruction on an ABI 7500 (Life Technologies)
with following cycling program: 95◦C for 2 min followed by
40 cycles of 95◦C for 30 s, 58◦C for 15 s, and 68◦C for 30 s.
The primer sequences were listed in Table 1. The relative gene
expression level was calculated using 2−11Ct method with
β-actin or 18S rRNA as the internal control.
Isolation of Mitochondria from Mouse
Livers
Mitochondria were isolated from chow-fed C57BL/6, Lrpprc
transgenic, aav-shControl, and aav-shLrpprc mouse livers using
a previously described method (Frezza et al., 2007). Briefly,
liver tissue was rinsed 4–5 time in ice-cold isolation buffer (IB,
0.01 mol/L Tris–MOPS, 0.01 mol/L EGTA/Tris, and 0.2 mol/L
sucrose, pH 7.4) to clear all blood, minced into small pieces
on ice, homogenized (tissue: IB = 1: 10 w/v) using a pre-
cooled Teflon pestle at 1600 rpm for 4–5 strokes on ice. The
homogenate was transferred into 50 ml polypropylene Falcon
tube and centrifuged at 600 g for 10 min at 4◦C. The supernatant
was transferred into glass centrifuge tubes and centrifuged at
7000 g for 10 min at 4◦C. The supernatant was discarded and
the mitochondria pellet was washed twice with 5 ml cold IB and
centrifuged at 7000 g for 10 min at 4◦C before suspended in 1 ml
IB). The mitochondrial concentration was determined by Biuret
methods.
FIGURE 1 | LRPPRC does not influence mouse weight gain. The average weight of C57BL/6 and Lrpprc liver transgenic (A), aav-shCtrl and aav-shLrpprc (B)
mice (n = 10) during the 9 weeks fed with regular chow or high-fat diet. Data were expressed as mean ± SEM (n = 10). WT, C57BL/6 mice; Tg, Lrpprc liver
transgenic mice.
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Analysis of Mitochondrial Oxygen
Consumption
Mitochondria oxygen consumption of mouse liver was measured
on a Clarke-type electrode (Hansatech Instruments, Norfolk,
UK) as previously described (Liu et al., 2011) with minor
modifications. The amount of mitochondria equaling 0.5 µg
mitochondrial proteins was resuspended in 600 µl of respiration
buffer (25 mM glucose, 1 mM pyruvate, and 1% BSA in PBS)
and loaded onto the electrode. Oligomycin and myxothiazol
were added sequentially to evaluate uncoupled and non-OxPhos
oxygen consumption.
Analyses of the Enzymatic Activities of
OxPhos Complexes
The enzymatic activities of OxPhos complexes and citrate
synthase were measured using MitoCheck Complex Activity
Assay Kits (700930 for complex I, 700940 for complex II,
700950 for complex II/III, 700990 for complex IV, and 701000
for complex V, Cayman Chemical, Ann Arbor, MI), and
Citrate Synthase Activity Assay Kit (701040, Cayman Chemical)
according to manufacturer’s protocols.
Measurement of Liver ATP Level
Liver tissue pieces (about 100 µg) were homogenized and
extracted with previously described method (Ghanbari-Niaki
et al., 1999). All lysates were adjusted to the same µg liver / µl
before 50µl lysate being used for measurement using a CellTiter-
Glo Luminescent Cell Viability Assay kit (Promega, Madison,
WI) according to manufacturer’s protocol. The luminescent
signal was detected using a POLARstar Omega microplate reader
(BMG Labtech, Offenburg, Germany). The average liver ATP
levels of Lrpprc Tg or Lrpprc knockdown mice were normalized
against their respective control mice.
Palmitate Oxidation in Primary
Hepatocytes
Palmitate oxidation was performed as previously described
(Huynh et al., 2014) with modifications. Mouse primary
hepatocytes were isolated from 13 to 15 week old wild type,
Lrpprc transgenic, aav-shcontrol, and aav-shLrpprc male mice.
Mice were anesthetized by pentobarbital sodium (30 mg/kg)
intraperitoneally and hepatocytes were isolated with two-stage
collagenase perfusion methods (Li et al., 2010). The hepatocytes
were cultured in complete medium for 12 h followed by
being incubated in starvation medium (Liu et al., 2011) for
another 12 hr. Then the hepatocytes were incubated in pre-
incubation medium (1% BSA, 25 mM HEPES and 0.5 mM
Palmitate (P9767, Sigma-Aldrich, St Louis, MO) in DMEM)
for 60 min followed by incubating with 14C-palmitate (0.1
µCi/uL, 59 Ci/mmol, NEC075H050UC, Perkin Elmer, Waltham,
FIGURE 2 | LRPPRC upregulates the expression of mitochondrial genome encoded genes. The relative mRNA levels of mitochondrial genome encoded
genes (A,D) and nuclear genome encoded genes (B,E) of livers from WT and Lrpprc transgenic (A,B) or aav-shCtrl and aav-shLrpprc (D,E) tail-vein injected mice.
The protein levels of LRPPRC, COX1, and COX5A from Lrpprc transgenic (C) and knockdown (F) mice livers. Experiments were performed in triplicates. Data were
expressed as mean ± SEM (n = 10). WT, C57BL/6 mice; Tg, Lrpprc liver transgenic mice.
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MA) for 3 h. At the end of the incubation, 100 µL of
1 mol/L percholic acid was added into each well and filter
paper disk moistened with 2 mol/L KOH was immediately
placed over each well. Plates were sealed and rocked gently
for 60 min at room temperature. Paper disks were transferred
into scintillation vials with 4 ml scintillation fluid and
measured the average counts per minute over 3 min with
a LS 6500 Scintillation Counter (Beckman Coulter, Beijing,
China).
Palmitate Uptake by Primary Hepatocytes
Two procedures for palmitate uptake assay were similar
to aforementioned palmitate oxidation assay with following
changes.
Protocol 1. After starvation, hepatocytes were loaded with
cold palmitate in pre-incubation medium for 2 h and then
changed to 14C-palmitate for 30min before they were washed 5
times with washing buffer (1 mmol/L EDTA and 0.01% Tween 20
in 1x PBS, pH 7.4) and counted.
Protocol 2. After starvation, hepatocytes were cultured with
14C-palmitate-containing medium for 1 h, washed 3 times with
washing buffer, and then cultured in pre-incubation medium
with cold palmitate for 90min before being washed 5 times with
washing buffer and counted.
Statistical Analysis
All data were expressed as mean ± SEM. Statistical analyses
were performed using GraphPad (Prism). Differences
among groups were analyzed by either Student’s t-test
or by two-way ANOVA with Bonferroni’s post hoc test.
A p-values less than 0.05 was considered statistically
significant.
FIGURE 3 | LRPPRC increase oxidative phosphorylation and hepatic ATP level. (A) The hepatic ATP of WT, transgenic, aav-shCtrl, and aav-shLrpprc mice
was measured using CellTiter-Glo Luminescent Cell Viability Assay kit and the relative ATP levels were calculated against WT or aav-shCtrl mice. The hepatic
mitochondria respiration rates of WT and transgenic mice (B) and aav-shCtrl and aav-shLrpprc mice (C) were measured using a Clarke-type electrode. Experiments
were performed in triplicates. (D) The enzymatic activities of liver mitochondria oxidative phosphorylation complexes were assessed with specific assay kits. The
results were shown as percentage change over control (transgenic compared to wild type mice and aav-shLrpprc compare to aav-shControl mice). Data were
expressed as mean ± SEM (n = 10). WT, C57BL/6 mice; Tg, Lrpprc liver transgenic mice. *p < 0.05; **p < 0.01 by t-tests.
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RESULTS
Hepatic LRPPRC Level does not Influence
the Weight Gain of Mouse Fed with
High-Fat Diet
The initial body weight of all mice (8 week old) were 24–24.5 g.
The weekly weight gains of Lrpprc transgenic mice and wild type
C57BL/6 mice (Figure 1A) as well as those of aav-shLrpprc and
aav-shCtrl (Figure 1B) were very similar. High fat diet caused
faster weight gain in all groups (Figure 1).
LRPPRC Level Regulates Mitochondrial
Gene Expression
Overexpression of LRPPRC in mouse liver significantly
upregulated the transcript levels of genes encoded by
mitochondrial genome (mtDNA) (Figure 2A) but did not
increase the mRNA levels of nuclear genes involved in either
OxPhos (NDUFS1, SDHA, UQCRB, COX5A, and ATP5S)
or mitochondrial biogenesis (PGC-1α, PGC-1β, ERRα, and
Tfam) (Figure 2B). Accordingly, the protein level of mtDNA-
encoded cytochrome c oxidase subunit I (COX1) but not that
of nuclear genome (nDNA)-encoded COX5A was increased in
Lrpprc transgenic mouse liver (Figure 2C). On the other hand,
knockdown hepatic LRPPRCwith shRNA systematically reduced
the expression levels of mtDNA genes (Figures 2D,F) but did
not inhibit the expression of nDNA-encoded genes involved in
mitochondrial biogenesis or OxPhos (Figures 2E,F).
LRPPRC Increases Hepatic ATP Level and
Respiration Rate of Liver Mitochondria
The hepatic ATP level of aav-shLrpprc mice was 14% less than
that of aav-shCtrl mice whereas the hepatic ATP level of Lrpprc
transgenic mice was increased 17% over its control (Figure 3A).
The respiration rate of mitochondria from Lrpprc liver-
transgenic mouse liver was 48.8% higher than that of C57BL/6
wild type mouse liver (p < 0.01) with their proton leakage
was essentially at the same level (Figure 3B). After knockdown
hepatic LRPPRC with aav-shLrpprc, the respiration rate of
mitochondria isolated from those mouse livers was 36.6% less
than that of aav-shControl mouse liver mitochondria (p < 0.01)
whereas the proton leak was at similar level between the two
groups (Figure 3C).
The enzymatic activities of OxPhos complexes I, III, IV,
and V were 20–60% higher in Lrpprc transgenic mouse liver
FIGURE 4 | LRPPRC reduces hepatic and serum triglyceride and cholesterol levels. The fasting serum triglyceride (A), cholesterol (B), free fatty acids (C)
levels from WT, transgenic, aav-shCtrl, and aav-shLrpprc mice after being fed with high-fat diet for 9 weeks. (D) The changes of hepatic triglycerides and cholesterol
levels of mice fed with high-fat diet compared to regular chow fed mice. Data were expressed as mean ± SEM (n = 10). WT, C57BL/6 mice; Tg, Lrpprc liver
transgenic mice. *p < 0.05; **p < 0.01 by t-tests.
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mitochondria than those of wild type mice (p < 0.05) whereas
they were significantly reduced in Lrpprc knockdown mouse
liver mitochondria compared to shControl mice (Figure 3D).
However, LRPPRC did not impact the activities of complex II
(Figure 3D) and citrate synthase (data not shown).
LRPPRC Reduces Serum Triglyceride and
Cholesterol Levels
After 9 weeks of high-fat diet feeding, the fasting serum
triglyceride and cholesterol levels of Lrpprc liver transgenic
mice were significantly lower than those of wild type mice
(p < 0.05) whereas aav-shLrpprc mice had much higher serum
triglyceride and cholesterol levels than shControl mice (p <
0.01) (Figures 4A,B). The fasting free fatty acids levels were not
significantly altered by the changes of hepatic LRPPRC level
(Figure 4C).
High-fat diet induced the accumulation of triglyceride
and cholesterol in mouse liver of all genotypes studied
(Figure 4D). However, Lrpprc liver-specific transgene attenuated
the accumulation of hepatic triglyceride and cholesterol
whereas knockdown liver Lrpprc expression augmented hepatic
accumulation of triglyceride and cholesterol (Figure 4D).
Meanwhile, LRPPRC protected liver from damages caused
by high-fat diet (Figure 5). However, the mRNA levels
of genes involved in lipid metabolism including ACSM,
ACSL1, CPT-1a, MCAD, LCAD, HMGCS2, PPARα, and
PPARγ were not significantly changed in the livers of either
Lrpprc transgenic mice or Lrpprc knockdown mice (data not
shown).
FIGURE 5 | LRPPRC protects liver from high-fat diet caused damages.
Representative images of hematoxylin and eosin staining sections of livers
from wild-type mice (WT), and LRPPRC liver transgenic mice (Tg),
aav-shcontrol mice, and aav-shLrpprc mice.
Fatty Acid Uptake and Oxidation in
Hepatocytes are Increased by LRPPRC
To further delineate the mechanisms underlying the
accumulation of triglycerides and cholesterols in mouse
liver and serum, primary hepatocytes isolated from mice with
different Lrpprc genotypes were used to analyze palmitate uptake
and oxidation in vitro. Hepatocytes from Lrpprc transgenic
mice produced about 50% more CO2 than wild type hepatocytes
did (Figure 6A) whereas hepatocytes from Lrpprc silencing
mice produced about 40% less CO2 than control hepatocytes
(Figure 6D).
The rate of palmitate uptake by hepatocytes with different
Lrpprc levels was examined. After incubating 30 min with
14C-palmitate, hepatocytes from Lrpprc transgenic had about
20% more radioactive count than wild type hepatocytes
(Figure 6B) whereas hepatocytes from Lrpprc knockdown mice
obtained about 19% less radioactivity than control hepatocytes
(Figure 6E). In a different setting, the hepatocytes were loaded
with 14C-palmitate first and followed by chasing with cold
palmitate for 2 h. The remaining radioactivity in hepatocytes
from Lrpprc transgenic mice was 11% less than that in wild type
hepatocytes (Figure 6C) whereas silencing Lrpprc in hepatocytes
resulted in an increase of about 15% radio count (Figure 6F).
DISCUSSION
Overexpression of Lrpprc in mouse liver significantly elevated
hepatic OxPhos through increasing the expression of OxPhos
genes encoded by mitochondrial genome, which resulted
in the increase of hepatic ATP levels and reduction of
serum triglyceride and cholesterol levels. Moreover, Lrpprc
overexpression increased the uptake and oxidation of fatty acids
by hepatocytes. Knocking-down hepatic Lrpprc level caused the
opposite effects. The accumulation of triglyceride and cholesterol
in the livers of high fat diet fed mice was exacerbated by Lrpprc
knockdown but inhibited by Lrpprc liver-specific transgene.
However, Lrpprc did not have any effects on the genes involved
in mitochondria biogenesis or lipid metabolism.
Livers played a central role in lipids metabolism as it served
as the major organ for fatty acid oxidation and de novo fatty
acid biosynthesis. The imbalance between lipid influx (including
lipogenesis and lipid uptake) and lipid out flux (including
lipolysis and secretion into circulation) caused the changes
of hepatic and serum lipid levels (Koo, 2013). It has been
shown that depressed fatty acid β-oxidation due to reduced
mitochondrial OxPhos protein contents resulted in elevated
lipogenesis (Perfield et al., 2013) and Tg secretion (Diraison
et al., 2003). Current study showed that LRPPRC significantly
increased the activities of OxPhos complexes I, III, IV, and
V, which had critical components encoded by mitochondrial
genome. On the other hand, the activities of complex II and
citrate synthase, both lacked protein encoded by mitochondrial
genome, were not altered by the changes of LRPPRC level. The
increased OxPhos complex activities led to enhanced fatty acid
uptake and oxidation by hepatocytes as well as higher ATP level
in mouse liver. LRPPRC promoted OxPhos by upregulating the
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FIGURE 6 | LRPPRC promotes fatty acids uptake and oxidation by hepatocytes. After incubated with 14C-palmitate for 3 h, the 14C in CO2 was counted
(A,D). The 14C counts of hepatocytes after culturing with cold palmitate for 2 h followed by incubation with 14C-palmitate for 30 min (B,E) or incubating with
14C-palmitate for 1 h followed by cold palmitate for 90 min (C,F). The experiments were independently performed 3 times with triplicates. WT, C57BL/6 mice; Tg,
Lrpprc liver transgenic mice. *p < 0.01 Tg vs. WT or shLrpprc vs. shControl by t-test.
expression of mitochondrial genome-encoded OxPhos genes,
increasing the amount of assembled OxPhos complexes, and
improving the efficiency of mitochondrial OxPhos (Liu et al.,
2011), which would reduce the pool of acetyl-CoA and slow
down de novo lipogenesis (Figure 7) without changing the
expression of genes involved in lipid homeostasis. We defined
this phenomenon as “OxPhos funnel effect” where efficient
electron transport chain and ATP synthase complexes consumed
increased amount of NADH and FADH2, which drove the
uptake and oxidation of fatty acid and shifted the balance
away from lipogenesis and releasing lipids into circulation from
liver. Consequently, increased hepatic LRPPRC and OxPhos
rate resulted in the reduction of serum and hepatic triglyceride
and cholesterol levels (Figure 7), which would lower the risk of
atherosclerosis and other cardiovascular diseases (Lamarre et al.,
2013).
Liver specific PGC-1β transgene increased hepatic OxPhos
and induced enzymes involved in fatty acid oxidation and hepatic
VLDL secretion, which provided protection against liver lipid
overload and fibrosis but adversely increased the secretion of
triglyceride into circulation (Bellafante et al., 2013). In ob/ob
mouse liver, the expression of genes promoting mitochondria
biogenesis (PGC-1α and Tfam) was increased but mitochondrial
OxPhos proteins and OxPhos activities were reduced, which
caused the increase of de novo lipogenesis and hepatic triglyceride
level (Perfield et al., 2013). LRPPRC-driven hepatic OxPhos
activities promoted complete oxidation of fatty acids, reduced
liver triglyceride level, and protected against NAFLD (Akie et al.,
2015). The results of current study were in agreement with
the reported liver protecting effects of LRPPRC (Akie et al.,
2015) and further demonstrated for the first time that LRPPRC-
driven OxPhos could reduce serum lipid contents via promoting
hepatic fatty acids uptake and oxidation. The abundant ATP
from OxPhos and acetyl-CoA from fatty acid oxidation enabled
hepatocytes to produce glucose and/or ketone body for brain and
other tissues to use as energy sources during fasting (Liu et al.,
2011).
In conclusion, LRPPRC increases the expression of OxPhos
genes encoded by mitochondrial genome and enhances OxPhos
activities. Increased hepatic OxPhos capacity drives the uptake
and oxidation of fatty acids by hepatoicytes, leading to the
reduction of hepatic and circulating triglyceride and cholesterol
levels without disturbing other cellular and physiological
pathways. These data delineated a link between hepatic OxPhos
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FIGURE 7 | A proposed model of how hepatic LRPPRC regulates hepatic and circulating triglycerides and cholesterol. LRPPRC promotes the expression
of genes of mitochondrial genome, resulting in more efficient oxidative phosphorylation complexes to drive fatty acid oxidation and utilization of acetyl-CoA by Kreb’s
cycle, which would deplete cytosolic acetyl-CoA pool and in turn slows down the de novo lipogenesis and cholesterol biosynthesis. Tag, triglyceride; FA, fatty acid;
ac-CoA, acetyl-CoA.
level with the accumulation of hepatic and circulating lipid
levels, which may yield new insight into developing strategies for
preventing and treating metabolic and cardiovascular diseases.
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